
Wednesday, May 28, 2025 11:06:37 AM
I’ll think of you in a favorable way. I'll assume you’re a professional person who’s simply disappointed things haven’t played out as you hoped. First of all, the company continues working towards the goal. A lot of companies quit and AXXA didn't. For a moment, consider the possibility that the team at AXXA actually cares about executing on the plan they’ve laid out. There’s tangible progress, reducing debt, acquiring new resources, adapting to shifting market conditions, and yes, they have been in crypto for years. These aren’t signs of a company standing still, they’re signs of one working toward long-term positioning.
I also know firsthand that people working at Axxa are high-quality individuals who are doing real work. What's your profession? Let's imagine it's you and you're a doctor who sees patients every day, doing your best to help, and someone repeatedly calls you a scam despite your efforts. How would that feel?
Unfortunately, in the OTC world, noise is common, and some seem to thrive on it. But real investors look past the noise. They examine fundamentals, strategic execution, and the trajectory. Certain things take years to transpire and we are seeing signs that turn around is not as far as it could have been. That’s what I’m focused on. Not sarcasm, not outrage. Because often, the loudest critics are the ones who miss the biggest turnarounds.
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM